CVE-2023-44001: n/a in n/a
An issue in Ailand clinic mini-app on Line v13.6.1 allows attackers to send crafted malicious notifications via leakage of the channel access token.
AI Analysis
Technical Summary
CVE-2023-44001 is a medium-severity vulnerability identified in the Ailand clinic mini-app integrated within Line version 13.6.1. The vulnerability arises due to the leakage of the channel access token, which is a sensitive credential used to authenticate and authorize communication between the mini-app and the Line platform. An attacker who obtains this token can exploit it to send crafted malicious notifications to users of the mini-app. These notifications could potentially be used for phishing, social engineering, or delivering malicious payloads, thereby compromising user trust and security. The vulnerability requires network access (AV:N), low attack complexity (AC:L), and privileges (PR:L), but does not require user interaction (UI:N). The impact affects confidentiality and integrity but not availability. The scope is unchanged, meaning the exploit affects only the vulnerable component without extending to other components. The CVSS score of 5.4 reflects a medium severity level, indicating a moderate risk that should be addressed promptly. No known exploits are currently reported in the wild, and no patches or vendor advisories are listed, suggesting that mitigation may require custom or interim controls until an official fix is released.
Potential Impact
For European organizations, especially those leveraging Line's platform or the Ailand clinic mini-app for healthcare or customer engagement services, this vulnerability poses a risk of unauthorized notification delivery. This could lead to targeted phishing campaigns or misinformation dissemination, potentially compromising patient data confidentiality and undermining trust in digital health services. Healthcare providers and related service platforms are particularly sensitive to such breaches due to regulatory requirements like GDPR, which mandates strict protection of personal data. The leakage of access tokens could also facilitate lateral movement or further exploitation if attackers combine this with other vulnerabilities. While the direct impact on availability is minimal, the reputational damage and potential regulatory penalties could be significant. Organizations relying on Line's ecosystem for communication should be vigilant and assess their exposure to this vulnerability.
Mitigation Recommendations
1. Immediate revocation and regeneration of channel access tokens associated with the Ailand clinic mini-app to prevent misuse of leaked credentials. 2. Implement strict access controls and monitoring on token usage to detect anomalous notification sending patterns. 3. Employ network segmentation and limit the exposure of the mini-app backend to reduce the attack surface. 4. Conduct thorough code reviews and security assessments of the mini-app to identify and remediate token leakage vectors. 5. Educate users and administrators about the risks of malicious notifications and encourage verification of unexpected messages. 6. Monitor official Line platform updates and security advisories for patches or fixes addressing this vulnerability and apply them promptly. 7. Consider deploying Web Application Firewalls (WAF) or Intrusion Detection Systems (IDS) tuned to detect suspicious notification traffic patterns related to this vulnerability.
Affected Countries
Germany, France, United Kingdom, Netherlands, Sweden
CVE-2023-44001: n/a in n/a
Description
An issue in Ailand clinic mini-app on Line v13.6.1 allows attackers to send crafted malicious notifications via leakage of the channel access token.
AI-Powered Analysis
Technical Analysis
CVE-2023-44001 is a medium-severity vulnerability identified in the Ailand clinic mini-app integrated within Line version 13.6.1. The vulnerability arises due to the leakage of the channel access token, which is a sensitive credential used to authenticate and authorize communication between the mini-app and the Line platform. An attacker who obtains this token can exploit it to send crafted malicious notifications to users of the mini-app. These notifications could potentially be used for phishing, social engineering, or delivering malicious payloads, thereby compromising user trust and security. The vulnerability requires network access (AV:N), low attack complexity (AC:L), and privileges (PR:L), but does not require user interaction (UI:N). The impact affects confidentiality and integrity but not availability. The scope is unchanged, meaning the exploit affects only the vulnerable component without extending to other components. The CVSS score of 5.4 reflects a medium severity level, indicating a moderate risk that should be addressed promptly. No known exploits are currently reported in the wild, and no patches or vendor advisories are listed, suggesting that mitigation may require custom or interim controls until an official fix is released.
Potential Impact
For European organizations, especially those leveraging Line's platform or the Ailand clinic mini-app for healthcare or customer engagement services, this vulnerability poses a risk of unauthorized notification delivery. This could lead to targeted phishing campaigns or misinformation dissemination, potentially compromising patient data confidentiality and undermining trust in digital health services. Healthcare providers and related service platforms are particularly sensitive to such breaches due to regulatory requirements like GDPR, which mandates strict protection of personal data. The leakage of access tokens could also facilitate lateral movement or further exploitation if attackers combine this with other vulnerabilities. While the direct impact on availability is minimal, the reputational damage and potential regulatory penalties could be significant. Organizations relying on Line's ecosystem for communication should be vigilant and assess their exposure to this vulnerability.
Mitigation Recommendations
1. Immediate revocation and regeneration of channel access tokens associated with the Ailand clinic mini-app to prevent misuse of leaked credentials. 2. Implement strict access controls and monitoring on token usage to detect anomalous notification sending patterns. 3. Employ network segmentation and limit the exposure of the mini-app backend to reduce the attack surface. 4. Conduct thorough code reviews and security assessments of the mini-app to identify and remediate token leakage vectors. 5. Educate users and administrators about the risks of malicious notifications and encourage verification of unexpected messages. 6. Monitor official Line platform updates and security advisories for patches or fixes addressing this vulnerability and apply them promptly. 7. Consider deploying Web Application Firewalls (WAF) or Intrusion Detection Systems (IDS) tuned to detect suspicious notification traffic patterns related to this vulnerability.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- mitre
- Date Reserved
- 2023-09-25T00:00:00.000Z
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 6839c098182aa0cae2b3b6cd
Added to database: 5/30/2025, 2:28:40 PM
Last enriched: 7/8/2025, 7:26:09 PM
Last updated: 7/21/2025, 1:03:38 PM
Views: 7
Related Threats
CVE-2025-45767: n/a
HighCVE-2025-46018: n/a
HighCVE-2025-41376: CWE-89 Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in TESI Gandia Integra Total
HighCVE-2025-41375: CWE-89 Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in TESI Gandia Integra Total
HighCVE-2025-41374: CWE-89 Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in TESI Gandia Integra Total
HighActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.